| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1023/A:1021425004264 |
| P698 | PubMed publication ID | 12523654 |
| P2093 | author name string | A N Tony Kong | |
| Khew-Voon Chin | |||
| P2860 | cites work | Initial sequencing and analysis of the human genome | Q21045365 |
| The Sequence of the Human Genome | Q22065842 | ||
| Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast | Q24321410 | ||
| Isolation of cDNA encoding the human NF-E2 protein | Q24563782 | ||
| Keap1 represses nuclear activation of antioxidant responsive elements by Nrf2 through binding to the amino-terminal Neh2 domain | Q24609907 | ||
| Cluster analysis and display of genome-wide expression patterns | Q24644463 | ||
| Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene | Q24649776 | ||
| The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma | Q27824784 | ||
| Gene expression profiling predicts clinical outcome of breast cancer | Q27860732 | ||
| Quantitative monitoring of gene expression patterns with a complementary DNA microarray | Q27861102 | ||
| hMAF, a small human transcription factor that heterodimerizes specifically with Nrf1 and Nrf2 | Q28241711 | ||
| Gene-expression profiles predict survival of patients with lung adenocarcinoma | Q29614443 | ||
| High density synthetic oligonucleotide arrays | Q29616560 | ||
| Application of complementary DNA microarray technology to carcinogen identification, toxicology, and drug safety evaluation. | Q30790297 | ||
| Mutational analysis using oligonucleotide microarrays | Q33755554 | ||
| Signal transduction events elicited by cancer prevention compounds | Q34338131 | ||
| Gene expression of TPA induced differentiation in HL-60 cells by DNA microarray analysis | Q34368407 | ||
| Induction of xenobiotic enzymes by the MAP kinase pathway and the antioxidant or electrophile response element (ARE/EpRE). | Q34478999 | ||
| Pharmacogenomics, regulation and signaling pathways of phase I and II drug metabolizing enzymes | Q34946568 | ||
| Gene microarray identification of redox and mitochondrial elements that control resistance or sensitivity to apoptosis | Q35079106 | ||
| Regulation of the antioxidant response element by protein kinase C-mediated phosphorylation of NF-E2-related factor 2 | Q35814343 | ||
| Number of CpG islands and genes in human and mouse | Q36738077 | ||
| Activation of mitogen-activated protein kinase pathways induces antioxidant response element-mediated gene expression via a Nrf2-dependent mechanism | Q38308355 | ||
| Assembly, annotation, and integration of UNIGENE clusters into the human genome draft | Q40414920 | ||
| Phosphatidylinositol 3-kinase, not extracellular signal-regulated kinase, regulates activation of the antioxidant-responsive element in IMR-32 human neuroblastoma cells | Q43556602 | ||
| 26 S proteasome-mediated degradation of topoisomerase II cleavable complexes. | Q43730370 | ||
| Monitoring the expression profiles of doxorubicin-induced and doxorubicin-resistant cancer cells by cDNA microarray. | Q54040435 | ||
| The toxicity of menadione and mitozantrone in human liver-derived Hep G2 hepatoma cells | Q60517658 | ||
| Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling | Q61910882 | ||
| P433 | issue | 12 | |
| P921 | main subject | pharmacogenomics | Q1152227 |
| P304 | page(s) | 1773-1778 | |
| P577 | publication date | 2002-12-01 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | Application of DNA microarrays in pharmacogenomics and toxicogenomics | |
| P478 | volume | 19 |
| Q38107202 | A glance at DNA microarray technology and applications |
| Q35605265 | Advances in pharmacogenomic research and development |
| Q24805862 | Analysis of host response to bacterial infection using error model based gene expression microarray experiments. |
| Q94101549 | Current Awareness on Comparative and Functional Genomics |
| Q28390730 | Designing toxicogenomics studies that use DNA array technology |
| Q40665215 | Differential responses from seven mammalian cell lines to the treatments of detoxifying enzyme inducers. |
| Q36808197 | Effects of cardiotonic steroids on dermal collagen synthesis and wound healing |
| Q38163465 | Emerging technologies and challenges for better and safer drugs |
| Q23914178 | Environmental health research in the post-genome era: new fields, new challenges, and new opportunities |
| Q51570050 | Gene expression signature for recurrence in stage III colorectal cancers. |
| Q33708586 | Magnetic scanometric DNA microarray detection of methyl tertiary butyl ether degrading bacteria for environmental monitoring |
| Q35207557 | Microarray technology--an intellectual property retrospective |
| Q36467321 | New strategies in drug discovery |
| Q34981527 | Novel multistranded, alternative, plasmid and helical transitional DNA and RNA microarrays: implications for therapeutics |
| Q85241229 | RNA and DNA Microarrays |
| Q37121662 | Recent advances in 2D and 3D in vitro systems using primary hepatocytes, alternative hepatocyte sources and non-parenchymal liver cells and their use in investigating mechanisms of hepatotoxicity, cell signaling and ADME. |
| Q30986903 | The use of toxicogenomic data in risk assessment: a regulatory perspective |
| Q37380576 | Variability of DNA microarray gene expression profiles in cultured rat primary hepatocytes. |
Search more.